Cosentyx (secukinumab) and Humira (adalimumab) are prescription drugs used to treat similar conditions. Both drugs come as subcutaneous injections, however, Cosentyx may also be given as an intravenous (IV) injection. Cosentyx and Humira are both brand-name drugs.
This article explains the main ways Cosentyx and Humira are alike and different. Your doctor can discuss the benefits and risks of these and other treatment options based on your individual diagnosis and medical history.
For more information about these drugs, including details about their uses, see this Cosentyx article and this Humira article.
See the following lists to find out whether Cosentyx or Humira is available as a biosimilar. (Biosimilars are like generic drugs. But unlike generics, which are made for nonbiologic drugs, biosimilars are made for biologic drugs.)
- Cosentyx:
- Available as a biosimilar: no
- Active ingredient: secukinumab
- Humira:
- Available as a biosimilar: yes
- Active ingredient: adalimumab
If your doctor prescribes Cosentyx or Humira and you’re interested in using the biosimilar version instead, talk with your doctor or pharmacist.
Cosentyx and Humira are both prescribed to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and hidradenitis suppurativa (a type of skin condition). Both medications have other uses as well.
The following table includes details on the conditions each drug treats.
Use | Cosentyx | Humira |
---|---|---|
plaque psoriasis | ✓ | ✓ |
psoriatic arthritis | ✓ | ✓ |
ankylosing spondylitis | ✓ | ✓ |
hidradenitis suppurativa (a type of skin condition) | ✓ | ✓ |
nonradiographic axial spondyloarthritis (which doesn’t show up on X-rays) | ✓ | |
enthesitis-related arthritis | ✓ | |
rheumatoid arthritis | ✓ | |
juvenile idiopathic arthritis | ✓ | |
Crohn’s disease | ✓ | |
ulcerative colitis | ✓ | |
uveitis (a type of eye condition) | ✓ |
To learn more about using Cosentyx or Humira to treat your condition, talk with your doctor.
Cosentyx is used to treat the following conditions in children:
- plaque psoriasis in children ages 6 years and older
- psoriatic arthritis in children ages 2 years and older
- enthesitis-related arthritis in children ages 4 years and older
Humira is used to help treat the following conditions in children:
- juvenile idiopathic arthritis in children ages 2 years and older
- Crohn’s disease in children ages 6 years and older
- ulcerative colitis in children ages 5 years and older
- hidradenitis suppurativa in children ages 12 years and older
- uveitis in children ages 2 years and older
For more information about the use of either drug in children, talk with your child’s doctor.
Here’s an overview of Cosentyx and Humira dosages and how you would use these drugs for the conditions they both treat.
Cosentyx and Humira are also used to treat other conditions, but those uses aren’t addressed here. To learn more about the dosages for all conditions these drugs treat, see the Cosentyx dosage article and Humira dosage article.
Depending on the condition being treated, you may receive Cosentyx as a subcutaneous (under the skin) injection or IV infusion (injection given into the vein slowly over time). However, the IV infusion is only given by a healthcare professional. It’s also only given to adults in certain conditions.
The following dosage information will focus on the subcutaneous injection form of Cosentyx. To learn more about the dosage of the IV infusion, see the Cosentyx dosage article.
Forms and strengths
The following information highlights the forms and strengths available for Cosentyx and Humira. Strengths are given in milligrams per milliliter (mg/mL).
Forms
Cosentyx comes as a liquid solution inside:
- single-dose prefilled injection pens
- single-dose prefilled syringes
Humira comes as a liquid solution inside:
- single-dose prefilled injection pens
- single-dose prefilled syringes
- single-dose vials
Strengths
Cosentyx comes in the following forms:
- single-dose prefilled injection pens: 150 mg/mL, 300 mg/2 mL
- single-dose prefilled syringes: 75 mg/0.5 mL, 150 mg/mL, 300 mg/2 mL
Humira comes in the following forms:
- single-dose prefilled injection pens: 40 mg/0.4 mL, 40 mg/0.8 mL, 80 mg/0.8 mL
- single-dose prefilled syringes: 10 mg/0.1 mL, 10 mg/0.2 mL, 20 mg/0.2 mL, 20 mg/0.4 mL, 40 mg/0.4 mL, 40 mg/0.8 mL, 80 mg/0.8 mL
- single-dose vials: 40 mg/0.8 mL
Dosage for plaque psoriasis
The following information highlights the recommended dosages of Cosentyx and Humira for plaque psoriasis.
Cosentyx for plaque psoriasis
The typical dosage of Cosentyx for adults for treating plaque psoriasis is 300 mg once weekly for the first 5 weeks. After that, your doctor will likely change your dosage to 300 mg once every 4 weeks.
Humira for plaque psoriasis
The typical dosage of Humira for adults for treating plaque psoriasis starts with an initial loading dose of 80 mg. Then, 1 week later, your doctor will likely change your dosage to 40 mg once every other week.
Administration
Cosentyx and Humira are injected under the skin. The instructions on how to administer an injection differ depending on the form of the drug you’re prescribed. Your doctor will show you how to give yourself injections. You can also read the instructions for use in the prescribing information for Cosentyx and Humira.
Dosage for psoriatic arthritis
The following table highlights the recommended dosages of Cosentyx and Humira for psoriatic arthritis.
Cosentyx for psoriatic arthritis | Humira for psoriatic arthritis | |
---|---|---|
Dose | depends on the treatment plan your doctor prescribes for you | 40 mg |
How often to use | depends on the treatment plan your doctor prescribes for you | once every other week |
Dosage for ankylosing spondylitis
The following table highlights the recommended dosages of Cosentyx and Humira for ankylosing spondylitis.
Cosentyx for ankylosing spondylitis | Humira for ankylosing spondylitis | |
---|---|---|
Dose | depends on the treatment plan your doctor prescribes for you | 40 mg |
How often to use | depends on the treatment plan your doctor prescribes for you | once every other week |
Dosage for hidradenitis suppurativa
The following information highlights the recommended dosages of Cosentyx and Humira for hidradenitis suppurativa.
Cosentyx for hidradenitis suppurativa
The typical dosage for adults for treating hidradenitis suppurativa is 300 mg once weekly for the first 5 weeks. After that, your doctor will likely change your dosage to 300 mg once every 4 weeks.
Humira for hidradenitis suppurativa
The typical dosage for adults for treating hidradenitis suppurativa is an initial loading dose of 160 mg injected as one dose in 1 day or split into two doses given over 2 days.
Then, 2 weeks later, starting on day 15, your doctor will likely change your dose to 80 mg. On day 29 and afterward, you’ll likely use 40 mg once weekly or 80 mg once every other week.
Cosentyx and Humira may cause side effects ranging from mild to serious.
For more information about possible side effects, see the Cosentyx side effects article and Humira side effects article.
Mild side effects
Cosentyx and Humira may cause mild side effects. The following table lists examples of mild side effects that have been reported with these drugs.
Cosentyx | Humira | |
---|---|---|
upper respiratory infections, such as the common cold | ✓ | ✓ |
diarrhea | ✓ | |
cold sores | ✓ | |
headache | ✓ | ✓ |
rash | ✓ | ✓ |
nausea | ✓ | ✓ |
injection site reactions, such as itching, pain, or swelling where the medication is injected | ✓ | |
back pain | ✓ |
This table may not include all mild side effects of these drugs. For more information on mild side effects, see the Cosentyx prescribing information and Humira prescribing information.
Serious side effects
Serious side effects may also occur in people using Cosentyx or Humira. The following table includes side effects reported with these drugs.
Cosentyx | Humira | |
---|---|---|
risk of serious infections (see “What are the warnings for Cosentyx and Humira?”) | ✓ | ✓ |
inflammatory bowel disease | ✓ | |
severe skin reactions | ✓ | |
heart problems, including heart failure | ✓ | |
lupus-like syndrome (a type of immune system reaction) | ✓ | |
nerve problems | ✓ | |
blood disorders, including anemia (low red blood cell levels) | ✓ | |
liver damage | ✓ | |
risk of cancer (see “What are the warnings for Cosentyx and Humira?”) | ✓ |
To learn about your specific risk of serious side effects from Cosentyx or Humira, talk with your doctor or pharmacist.
Allergic reactionFor some people, Cosentyx or Humira can cause an allergic reaction. This side effect was reported in studies of both Cosentyx and Humira.
In general, symptoms of an allergic reaction can be mild or serious.
What might help
If you have mild symptoms of an allergic reaction, such as a mild rash, call your doctor right away. They may suggest a treatment to manage your symptoms and can determine whether you should keep using Cosentyx or Humira.
If you have symptoms of a severe allergic reaction, such as swelling or trouble breathing, call 911 or your local emergency number right away. These symptoms could be life threatening and require immediate medical care.
If your doctor confirms you’ve had a serious allergic reaction to Cosentyx or Humira, they may have you switch to a different treatment.
Cosentyx and Humira are both used to treat similar conditions, including plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and hidradenitis suppurativa. Studies of Cosentyx and Humira have shown that both drugs are effective for these uses.
In addition, the National Psoriasis Foundation includes both drugs in its treatment recommendations for plaque psoriasis and psoriatic arthritis. The
It’s important to note that your results from Cosentyx or Humira may differ from those reported in studies. Talk with your doctor about whether one of these drugs is right for you.
Whether you have health insurance or not, cost may be a factor when you’re considering these drugs.
Keep in mind that what you’ll pay for either drug will depend on your treatment plan, health insurance, and the pharmacy you use. If you’re receiving the IV infusion form of Cosentyx, it may also depend on the cost of the visit to your healthcare professional to receive doses of Cosentyx.
Cosentyx and Humira are both brand-name drugs. Cosentyx isn’t available as a biosimilar.
Humira has several biosimilar versions available. A biologic drug is made from living cells, while other drugs are made from chemicals. Drugs made from chemicals can have generics, which are exact copies of the active drug in the brand-name medication. Biologics, on the other hand, cannot be copied exactly. So instead of a generic, biologics have biosimilars. Biosimilars are “similar” to the parent drug, and they’re considered to be just as effective and safe.
Like generics, biosimilars often cost less than brand-name medications. If you’re interested in using the biosimilar form of Humira, talk with your doctor.
For other resources that might help you save on the price of these drugs, see the Cosentyx cost article and Humira cost article.
Cosentyx and Humira may not be right for you if you have certain medical conditions or other factors that affect your health. The prescribing information for these drugs refers to these factors as warnings.
The drugs share some of the same warnings, but they also have different ones. Some of these warnings are mentioned here. Before you start using Cosentyx or Humira, be sure to talk with your doctor to check whether these warnings apply to you.
Boxed warnings
Humira has boxed warnings regarding the risks of serious infections and cancer. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous.
Risk of serious infections: Using Humira can increase your risk of developing serious infections, some of which can lead to hospitalization or death. These include tuberculosis (TB), invasive fungal infections, and sepsis (a life threatening illness that can occur from an infection).
Your risk of a serious infection is higher if you are taking other medications that weaken your immune system, such as methotrexate (Trexall, others) or corticosteroids.
If you develop any signs or symptoms of infections while using Humira, your doctor will likely have you stop using the medication.
Risk of cancer: Certain types of cancer, such as lymphoma, have occurred in people using Humira. In some cases, these cancers have led to death. Due to this risk, your doctor will likely weigh the risks and benefits of using Humira before you start treatment, especially if you’ve had cancer in the past.
Other warnings
In addition to boxed warnings, Cosentyx and Humira have other warnings.
Before using Cosentyx or Humira, talk with your doctor if any of the following conditions or health factors apply to you.
- Warnings for Cosentyx:
- if you have inflammatory bowel disease
- Warnings for Humira:
- if you have nervous system problems
- if you have liver problems
- if you have low blood cell counts
- if you have heart problems
- if you have lupus-like symptoms
- if you have a history of hepatitis B
- if you have a history of cancer
- Warnings for both Cosentyx and Humira:
- if you’ve had an allergic reaction to either drug or any of its ingredients
- if you have an allergy to latex
- if you’re pregnant or planning to become pregnant
- if you’re breastfeeding or planning to breastfeed
- if you have a current infection
- if you have a history of TB
The short answer: It’s possible.
Details: While Cosentyx and Humira can be used to treat similar conditions, they work differently in your body. If you feel one medication isn’t helping with your condition or you’re having side effects from one of the drugs, switching treatments is possible.
If you’re interested in switching medications, talk with your doctor. They can help determine whether it’s safe for you to switch treatments. If it is, they can explain the best way to do so.
Reminder: You should not switch drugs or stop your current treatment unless your doctor recommends it.
Disclaimer: Healthline has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.